Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: ppublish

Résumé

Among all natural and synthetic toxins, botulinum neurotoxins (BoNTs), produced by

Identifiants

pubmed: 38853516
doi: 10.1080/21645515.2024.2358570
doi:

Substances chimiques

Antibodies, Neutralizing 0
rimabotulinumtoxinB 0Y70779M1F
Botulinum Toxins, Type A EC 3.4.24.69
RNA, Messenger 0
Antibodies, Bacterial 0
Lipid Nanoparticles 0
Vaccines, Synthetic 0
Liposomes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2358570

Auteurs

Gulisaina Qiaerxie (G)

School of Medical Device, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Protein Engineering Laboratory, Beijing Institute of Biotechnology, Beijing, China.

Yujia Jiang (Y)

Protein Engineering Laboratory, Beijing Institute of Biotechnology, Beijing, China.

Gege Li (G)

School of Medical Device, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Protein Engineering Laboratory, Beijing Institute of Biotechnology, Beijing, China.

Zhixin Yang (Z)

Protein Engineering Laboratory, Beijing Institute of Biotechnology, Beijing, China.

Feng Long (F)

School of Medical Device, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Department of Pharmacy, Maternal and Child Health Care Hospital of Zaozhuang, Zaozhuang, Shandong, China.

Yunzhou Yu (Y)

Protein Engineering Laboratory, Beijing Institute of Biotechnology, Beijing, China.

Jian Sheng Lu (JS)

Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.

Peng Du (P)

Protein Engineering Laboratory, Beijing Institute of Biotechnology, Beijing, China.

Yong Cui (Y)

School of Medical Device, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH